Manchester is the third-largest metropolitan area in the UK, and you would expect it to have a private ketamine clinic. Our directory says otherwise, and we would rather tell you that plainly than pad a city page with providers who are not really here. As of September 2026 we list no verified private ketamine or ketamine-assisted psychotherapy clinic based in Manchester; the Manchester record we hold is a research site, and its study has closed recruitment. What the city does have is proximity — to a live northern trial corridor, to London's clinics, and to the cheapest supervised ketamine treatment in the country. This guide sets out that real map.
TL;DR There is no NHS ketamine or esketamine pathway in England — NICE did not recommend Spravato in TA854 — and no verified private ketamine clinic in Manchester in our directory. The realistic options are travelling — Eulas Clinics lists a Manchester site alongside its Edinburgh base and London locations, London's verified clinics are about two hours away, and Oxford Health's self-funded NHS service charges £265 per infusion with a referral letter — or the free research route: CYB003 Phase 3 depression sites are recruiting in Sheffield, Doncaster and Newcastle, and a 5-MeO-DMT study in Liverpool.
The routes at a glance
| NHS (England) | Private ketamine or KAP | NHS trust, self-funded (Oxford) | Clinical trial (North of England) | |
|---|---|---|---|---|
| What it is | No routine pathway — esketamine not recommended by NICE, ketamine off-label and never appraised; limited pilots at Oxford Health and CNWL reached via NHS referral | Off-label IV ketamine infusions or KAP programmes — currently a travel option from Manchester | Off-label IV ketamine inside an NHS trust's own service | Study medicine under research protocol |
| Who can use it | Effectively no one outside pilots and existing secondary-care pathways | Self-referral is widely accepted, but suitability is established by a full clinical assessment — diagnosis and severity, previous treatment, comorbidity, current medicines and substance use, risk and consent — not by passing an initial screen | Anyone with a referral letter from a GP or psychiatrist, subject to the service's intake rules | Study-specific criteria; strict screening |
| Cost | — | £300–800 per infusion (£595 the published London figure); programmes from ~£6,000 | £265 per infusion and per initial assessment; budget ~£3,000/year | Free |
| How to start | Ask your psychiatrist if you are already in secondary care | Contact the clinic directly and ask where dosing happens | GP or psychiatrist referral letter, then an assessment usually held online | Registry search plus screening |
Why the map looks like this
Start with the honest baseline: there is no standard NHS ketamine pathway for depression in England. Racemic ketamine is licensed as an anaesthetic and used off-label as an antidepressant, so NICE has never appraised it for routine commissioning; the related nasal spray esketamine was appraised and not recommended in TA854 on cost-effectiveness grounds. Scotland's medicines body went the other way — the postcode detail is in our UK reimbursement guide — but in England the treatment exists only where a private market or an NHS trust's own initiative has built it. The private market has concentrated in London; the NHS pilots of racemic ketamine run at Oxford Health and Central and North West London NHS Foundation Trusts (Magnetar/Blossom reimbursement report, 2025), both in the south, reached through NHS referral rather than direct booking. Manchester has neither layer yet.
If you are already in secondary care, ask your psychiatrist about the pilots before you spend a pound privately. And whatever route you take, the written treatment history — every antidepressant tried in the current episode, with dose, duration and outcome — carries the case. Bring it; it counts for more than anything you say in the room.
What is actually in Manchester
Two records, honestly framed. The Manchester entry in our directory is 4 Medical Clinical Solutions, a clinical research site that hosted the Phase 3 Panorama study of MM120 (lysergide) in generalised anxiety disorder — but recruitment for that study closed in 2026, so it is not a door you can currently walk through. And Eulas Clinics, the ketamine-assisted psychotherapy provider we have verified in Edinburgh, also lists sites in London and Manchester and publishes a six-week programme from around £6,000 — if a Manchester site would suit you, ask the clinic directly which location delivers assessment and which delivers dosing before you book, and verify the answer against the relevant register.
That is the whole local picture as we can verify it. Listings change — check the UK directory for the current state before assuming either way, and if you run or know a CQC-registered ketamine service in Greater Manchester, we want to hear about it.
The nearest in-person options
London, about two hours by train. The capital has the UK's densest private market: four verified clinics spanning consultant-led IV infusions and full KAP programmes, with £595 per infusion the published benchmark. Our London guide profiles each of them.
Oxford, self-funded inside the NHS. Oxford Health NHS Foundation Trust runs a self-funded ketamine service at £265 per infusion and per initial psychiatrist assessment, with £125 per scheduled review, open to patients with a referral letter from a GP or psychiatrist subject to its intake rules — the assessment itself usually happens online, and the service suggests budgeting around £3,000 per year. Genuinely NHS-funded treatment there is limited to Oxfordshire and Buckinghamshire patients referred by its own consultants, but the self-funded route is not catchment-limited. For a Manchester patient an induction course at those prices, travel included, may still undercut a private programme elsewhere — recent consensus describes roughly four to six infusions over two to four weeks as common practice rather than a licensed standard, and Oxford itself plans three to six over three to six weeks, individualised on response. The online assessment means the travel is for dosing days only.
Remote-plus-travel hybrids. The dosing itself is an in-clinic, supervised event at every provider we list — but assessment often is not. If travel is the constraint, ask a clinic whether it runs remote consultations with in-person dosing. Whichever you choose, verify before paying: the clinic's entry on the CQC register, the prescriber on the GMC register, the full course cost in writing, and what maintenance costs after the induction — the full checklist is in our clinic-choice guide. And plan the day: after a session you do not drive or do anything hazardous until the following day, after a restful sleep — our preparation checklist covers the practicalities. Our UK cost comparison sets all the routes against each other.
The research route: the North's strongest card
If cost is the constraint, trials are free by definition — legitimate studies never charge, and many reimburse travel. Here Manchester's position is genuinely good, because the recruiting northern sites are all within easy reach. Our directory lists Sheffield Health and Social Care NHS Foundation Trust and Clerkenwell Health's Doncaster site — both roughly an hour from Manchester — and the Wolfson Unit in Newcastle as sites recruiting for NCT06793397, Cybin's Phase 3 study of the deuterated psilocin analogue CYB003 in major depressive disorder. In Liverpool, MAC Clinical Research is a site for NCT05660642, Beckley Psytech's intranasal 5-MeO-DMT (BPL-003) study in treatment-resistant depression. Across the UK, 67 studies are tracked and 12 are active, spanning psilocybin, ketamine, DMT and esketamine.
Screening is strict and enrolment is never guaranteed, so treat trials as an option to check rather than a plan to rely on. Our trials guide explains how phases, placebo and consent work and how to search the registries; every legal route in the country is in our UK access guide.
Frequently asked questions
Is there a ketamine clinic in Manchester?
Not in our directory as of September 2026. The Manchester record we hold is a clinical trial site rather than a treatment service, and its study has closed recruitment; Eulas Clinics lists a Manchester site alongside its verified Edinburgh base, which is worth confirming directly with the clinic. Listings change, so check the UK directory for the current picture before assuming either way.
Can I get ketamine therapy on the NHS in Manchester?
No — there is no routine NHS pathway for ketamine or esketamine anywhere in England. NICE did not recommend esketamine (TA854), and racemic ketamine is off-label and has never been appraised. The limited NHS pilots run at Oxford Health and CNWL, reached through NHS referral; if you are already in secondary care, ask your psychiatrist.
What is the cheapest supervised option for someone in Manchester?
A clinical trial, if you fit one — participation is free, and CYB003 depression sites are recruiting in Sheffield and Doncaster, both about an hour away. For ketamine specifically, the cheapest supervised treatment in the UK is the NHS trust service in Oxford at £265 per infusion, self-funded, with the initial assessment usually held online so travel is for dosing days only.
What would private treatment cost if I travel?
At UK market rates: roughly £300–800 per infusion, with £595 the published London figure and full ketamine-assisted psychotherapy programmes from around £6,000 for six weeks. Ask for the full course cost in writing rather than a per-session price, and compare it against the £265 per infusion charged by the NHS trust service in Oxford.
Is Spravato an option in Manchester?
Not on the NHS — NICE's TA854 decision applies in England. Privately, esketamine is prescribable within its licence; as a price anchor, Oxford Health's own list puts self-pay Spravato at £591–754 per administration. Spravato and ketamine infusions are not interchangeable — see our side-by-side comparison.
Sources
- NICE TA854: Esketamine nasal spray for treatment-resistant depression — recommendations
- Oxford Health NHS FT: Interventional Psychiatry Service pricing
- Oxford Health NHS FT: Ketamine TRD service
- Eulas Clinics: ketamine therapy pricing
- The Burlington Clinic: ketamine therapy cost in London
- Reimbursement Pathways for Psychedelic Therapies in Europe — Magnetar Access × Blossom (2025)
- ClinicalTrials.gov: NCT06793397 — CYB003 Phase 3 in major depressive disorder
- ClinicalTrials.gov: NCT05660642 — BPL-003 (intranasal 5-MeO-DMT) in treatment-resistant depression
- ClinicalTrials.gov: NCT06809595 — MM120 Phase 3 in generalised anxiety disorder (Panorama)
- Blossom: United Kingdom country report
- Mathai et al. (2026), Journal of Affective Disorders — ASKP3 consensus guidelines on intravenous ketamine for depressive disorders
- CQC: Care Quality Commission register
This guide is for general information only and is not medical advice, a diagnosis, or a recommendation of any treatment. Regulations and prices change; always verify a provider's current registration with the relevant regulator, confirm fees in writing, and discuss your options with a licensed clinician who knows your history. If you are in crisis, contact your local emergency number or a crisis line immediately.
This guide awaits review by a licensed medical professional.